Adaptive Biotechnologies Stock Guidance | NASDAQ:ADPT

Comments

Adaptive Biotechnologies Corp Stock Guidance

ADPTNASDAQ

Trade with Public

$14.13

1.3410.48%

At close: Apr 13, 5:00 PM EST

$14.22

0.090.64%

After Hours: 4:04 PM EST

Overview News Earnings OptionsGuidanceAnalyst Ratings Insider Trades Short Interest Stock Report

Adaptive Biotechnologies (ADPT) last issued guidance on January 12, 2026 for fiscal year 2025. The company guided revenue in the range of $277.00M - $277.00M for the period.

Compared to prior guidance, Adaptive Biotechnologies raised its revenue forecast from a prior range of $72.00M - $72.00M.

Adaptive Biotechnologies has issued 11 guidance updates between May 4, 2022 and January 12, 2026. During this period, the company raised its outlook 4 times and lowered it 3 times, providing investors with insight into management's evolving expectations.

Latest Guidance Date

Jan 12, 2026

Guidance Period

Full Year 2025

Revenue Guidance Range

$277.00M - $277.00M

Adaptive Biotechnologies Guidance History

Review all historical guidance issued by Adaptive Biotechnologies, including EPS and revenue forecasts across quarterly and annual periods.

Loading calendar...

FAQ

What is the most recent guidance for Adaptive Biotechnologies (ADPT)?

The most recent guidance for Adaptive Biotechnologies (ADPT) was reported on January 12, 2026 for the fiscal year 2025. Adaptive Biotechnologies forecasted revenue between $277.00M and $277.00M for the period.

What revenue range did Adaptive Biotechnologies (ADPT) guide for?

Adaptive Biotechnologies (ADPT) guided revenue in the range of $277.00M to $277.00M for the fiscal year 2025.

Did Adaptive Biotechnologies (ADPT) raise or lower guidance?

Adaptive Biotechnologies (ADPT) raised its revenue guidance from a prior range of $72.00M - $72.00M to $277.00M - $277.00M for the fiscal year 2025.

When did Adaptive Biotechnologies (ADPT) last issue guidance?

Adaptive Biotechnologies (ADPT) last issued guidance on January 12, 2026 for the fiscal year 2025.

People Also Watch

Medpace Holdings Inc

NASDAQ:MEDP

$501.23

Agilent Technologies Inc

BioLife Solutions Inc

Adaptive Biotechnologies (ADPT) last issued guidance on January 12, 2026 for fiscal year 2025. The company guided revenue in the range of $277.00M - $277.00M for the period.

Compared to prior guidance, Adaptive Biotechnologies raised its revenue forecast from a prior range of $72.00M - $72.00M.

Latest Guidance Date

Jan 12, 2026

Guidance Period

Full Year 2025

Revenue Guidance Range

$277.00M - $277.00M

Adaptive Biotechnologies Guidance History

Review all historical guidance issued by Adaptive Biotechnologies, including EPS and revenue forecasts across quarterly and annual periods.

											Get Alert
01/12/2026	ADPT	Adaptive Biotechnologies	FY	2025	—	—	—	$277.00M	$277.00M	$264.48M	Get Alert
01/12/2026	ADPT	Adaptive Biotechnologies	Q4	2025	—	—	—	$72.00M	$72.00M	$59.17M	Get Alert
11/07/2024	ADPT	Adaptive Biotechnologies	FY	2024	—	—	—	$143.00M	$145.00M	$172.19M	Get Alert
08/01/2024	ADPT	Adaptive Biotechnologies	FY	2024	—	—	—	$140.00M	$145.00M	$167.87M	Get Alert
04/02/2024	ADPT	Adaptive Biotechnologies	Q1	2024	—	—	—	$41.00M	$43.00M	$38.21M	Get Alert
08/02/2023	ADPT	Adaptive Biotechnologies	FY	2023	—	—	—	$205.00M	$215.00M	$207.17M	Get Alert
05/03/2023	ADPT	Adaptive Biotechnologies	FY	2023	—	—	—	$205.00M	$215.00M	$208.52M	Get Alert
02/14/2023	ADPT	Adaptive Biotechnologies	FY	2023	—	—	—	$205.00M	$215.00M	$218.31M	Get Alert
11/03/2022	ADPT	Adaptive Biotechnologies	FY	2022	—	—	—	$185.00M	$190.00M	$187.45M	Get Alert
08/03/2022	ADPT	Adaptive Biotechnologies	FY	2022	—	—	—	$185.00M	$195.00M	$187.62M	Get Alert
05/04/2022	ADPT	Adaptive Biotechnologies	FY	2022	—	—	—	$185.00M	$195.00M	$189.38M	Get Alert

Loading calendar...

FAQ

What is the most recent guidance for Adaptive Biotechnologies (ADPT)?

What revenue range did Adaptive Biotechnologies (ADPT) guide for?

Adaptive Biotechnologies (ADPT) guided revenue in the range of $277.00M to $277.00M for the fiscal year 2025.

Did Adaptive Biotechnologies (ADPT) raise or lower guidance?

Adaptive Biotechnologies (ADPT) raised its revenue guidance from a prior range of $72.00M - $72.00M to $277.00M - $277.00M for the fiscal year 2025.

When did Adaptive Biotechnologies (ADPT) last issue guidance?

Adaptive Biotechnologies (ADPT) last issued guidance on January 12, 2026 for the fiscal year 2025.

People Also Watch

Medpace Holdings Inc

NASDAQ:MEDP

$501.23

Agilent Technologies Inc

BioLife Solutions Inc

											Get Alert
01/12/2026	ADPT	Adaptive Biotechnologies	FY	2025	—	—	—	$277.00M	$277.00M	$264.48M	Get Alert
01/12/2026	ADPT	Adaptive Biotechnologies	Q4	2025	—	—	—	$72.00M	$72.00M	$59.17M	Get Alert
11/07/2024	ADPT	Adaptive Biotechnologies	FY	2024	—	—	—	$143.00M	$145.00M	$172.19M	Get Alert
08/01/2024	ADPT	Adaptive Biotechnologies	FY	2024	—	—	—	$140.00M	$145.00M	$167.87M	Get Alert
04/02/2024	ADPT	Adaptive Biotechnologies	Q1	2024	—	—	—	$41.00M	$43.00M	$38.21M	Get Alert
08/02/2023	ADPT	Adaptive Biotechnologies	FY	2023	—	—	—	$205.00M	$215.00M	$207.17M	Get Alert
05/03/2023	ADPT	Adaptive Biotechnologies	FY	2023	—	—	—	$205.00M	$215.00M	$208.52M	Get Alert
02/14/2023	ADPT	Adaptive Biotechnologies	FY	2023	—	—	—	$205.00M	$215.00M	$218.31M	Get Alert
11/03/2022	ADPT	Adaptive Biotechnologies	FY	2022	—	—	—	$185.00M	$190.00M	$187.45M	Get Alert
08/03/2022	ADPT	Adaptive Biotechnologies	FY	2022	—	—	—	$185.00M	$195.00M	$187.62M	Get Alert
05/04/2022	ADPT	Adaptive Biotechnologies	FY	2022	—	—	—	$185.00M	$195.00M	$189.38M	Get Alert

Benzinga

Benzinga

Adaptive Biotechnologies Corp Stock Guidance

Adaptive Biotechnologies Guidance History

FAQ

What is the most recent guidance for Adaptive Biotechnologies (ADPT)?

What revenue range did Adaptive Biotechnologies (ADPT) guide for?

Did Adaptive Biotechnologies (ADPT) raise or lower guidance?

When did Adaptive Biotechnologies (ADPT) last issue guidance?

People Also Watch

Adaptive Biotechnologies Guidance History

FAQ

What is the most recent guidance for Adaptive Biotechnologies (ADPT)?

What revenue range did Adaptive Biotechnologies (ADPT) guide for?

Did Adaptive Biotechnologies (ADPT) raise or lower guidance?

When did Adaptive Biotechnologies (ADPT) last issue guidance?

People Also Watch